Evaluation of  Serum Fibrinogen, Plasminogen, <i>α</i>2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM

<table>Distribution of HbA1c within the groups.</table>

Journal of Diabetes Research

fig1

Figure 1

Figure 1: Evaluation of  Serum Fibrinogen, Plasminogen, <i>α</i>2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM 

Figure 1 | Evaluation of  Serum Fibrinogen, Plasminogen, α2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM 